|
|
|
| Overcoming Downstream Challenges in Next-Generation Antibody Development | How do you overcome the significant downstream purification and process challenges associated with turning next-generation antibodies into scalable, GMP-ready therapeutics? Implement a “design with the end in mind” approach, embedding commercial readiness into process development from the earliest stages. Join us October 8th at 11am ET/4pm BST to learn how. Click here to register. |
|
|
FOCUS ON PROCESS ENGINEERING |
|
|
|
A conversation with Diana Bowley, AbbVie | A custom-built digital ecosystem reduced the time spent on documentation in AbbVie's bioprocess development labs by about 70% for some experiment types. | |
|
|
| Time To Intensify: Taking mAb Manufacturing To The Next Level | White Paper | By Gerben Zijlstra and Jean-Marc Cappia, Sartorius | Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results. |
|
|
| Ingenuity & Instrumentation: Creating A Novel 4D Microscopy Method | Article | By Jenice Con Foo, Ph.D., Mad City Labs, Inc. | A team of Duke University researchers sought to explore the viral infection process before the virus has bonded to tissue, understanding how viruses navigate the epithelial space, through mucus and the periciliary layer. |
|
|
|
| Characterization, Impurity Profiling Of Combined Amylin And GLP-1 Analogs | Application Note | By Caitlin M. Hanna, Stephan M. Koza, and Steve Shiner, Waters Corporation | GLP-1 receptor agonists are transforming diabetes and weight loss treatment. Discover how to enable precise impurity analysis and characterization of complex, fatty acid-modified peptide therapeutics. |
|
|
| Closed System And Custom Solutions For Bioproduction | Webinar | Corning Life Sciences | Learn how closed system solutions offer process flexibility, reduce contamination risks, and can contribute to time saving or simplifying steps in manufacturing. Review customized solutions and key considerations. |
|
|
PROCESS ENGINEERING SOLUTIONS |
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development. Gain insights across cell culture, therapy development, and CGT manufacturing, and learn from world-renowned leaders Bobby Gaspar (Orchard Therapeutics), Christof Von Kalle, (Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
|
| Raw Materials Considerations When Manufacturing CGTs And Other Biologics | Poster | By Rebecca Warfield, Yanke Liu, Jane Liu, and Spencer Chiang, ACROBiosystems | Discover key considerations for qualifying GMP raw materials in cell and gene therapy manufacturing, emphasizing quality control, supplier selection, and regulatory compliance to ensure therapeutic safety and efficacy. |
|
|
| What You Need To Know About Fluoropolymer Bag Cold Chain Durability | Article | By Joe Cintavey and Meghan Meeuwissen, W.L. Gore & Associates | Drug manufacturers seek packaging that maintains integrity during processing and freezing, scales up to larger volumes easily, and remains robust throughout the temperature-controlled supply chain. |
|
|
| Connect With Bioprocess Online: |
|
|
|
